Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia 65Myelodysplastic Syndromes 64Leukemia, Myeloid, Acute 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 43Lymphoma 41Leukemia, Lymphocytic, Chronic, B-Cell 40Multiple Myeloma 35Hodgkin Disease 35Lymphoma, Non-Hodgkin 34Leukemia, Myeloid, Chronic-Phase 34Myeloproliferative Disorders 33Leukemia, Myeloid, Accelerated Phase 31Lymphoma, Follicular 28Lymphoma, B-Cell, Marginal Zone 28Congenital Abnormalities 28Burkitt Lymphoma 28Lymphoma, Mantle-Cell 27Lymphoma, Large B-Cell, Diffuse 27Neoplasms, Plasma Cell 23Lymphoma, Large-Cell, Immunoblastic 23Anemia, Refractory, with Excess of Blasts 23Blast Crisis 22Myelodysplastic-Myeloproliferative Diseases 19Leukemia, Myelomonocytic, Chronic 19Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Graft vs Host Disease 19Dendritic Cell Sarcoma, Interdigitating 19Primary Myelofibrosis 17Waldenstrom Macroglobulinemia 14Recurrence 14

Interventions

Thiotepa 2Melphalan 2Cyclophosphamide 2fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Muromonab-CD3 1Immunotherapy 1Drug Therapy 1Busulfan 1Antilymphocyte Serum 1Antibodies 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Histiocytosis × Antilymphocyte Serum × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡